SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (23925)8/4/1998 9:53:00 PM
From: CYBERKEN  Read Replies (1) | Respond to of 32384
 
Will the psoriasis trials be Phase II, or Phase I to get to optimal dosage?

Drugs-to-market definitely has slipped since I was last here, but I think the frequency and size of milestones will be unexpectedly increasing for the better development companies. Ligand has a lot of marketable development projects.



To: Henry Niman who wrote (23925)8/5/1998 12:47:00 AM
From: TI2, TechInvestorToo  Read Replies (2) | Respond to of 32384
 
When is/was earnings report?
TIA
TI2